Oral tolerance to low dose β2-glycoprotein I: Immunomodulation of experimental antiphospholipid syndrome

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5303-5312

  Blank, Miri ^a,b   George, Jacob ^a,b   Barak, Vivian ^c   Tincani, Angela ^d   Koike, Takao ^e   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d Clinical Immunology Unit   (Italy)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GLYCOPROTEINS; IMMUNE TOLERANCE; IMMUNITY, ACTIVE; INTUBATION, GASTROINTESTINAL; MALE; MICE; MICE, INBRED BALB C; SPLEEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032533475     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Harris, E. N., A. E. Gharavi, M. L. Boey, B. M. Patel, C. G. Mackworth-Young, S. Loizou, and G. R. V. Hughes. 1983. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211.
2. Asherson, R. A. 1989. A "primary" anti-phospholipid syndrome. J. Rheumatol. 15:1742.
3. Alarcon-Segovia. D., and J. Sanchez-Guerrero. 1986. Primary anti-phospholipid syndrome. J. Rheumatol. 16:482.
4. Hughes, G. R. V., E. N. Harris, and A. E. Gharavi. 1986. The anti-cardiolipin syndrome. J. Rheumatol. 13:486.
5. Lockshin, M. D. 1987. Anti-cardiolipin antibody. Arthritis Rheum. 30:471.
6. McNeil, H. P., C. N. Chesterman, and S. A. Krilis. 1991. Immunological and clinical importance of anti-phospholipid antibodies. Adv. Immunol. 49:193.
7. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum. 39:1466.
8. 2-glycoprotein I (apolipoprotein H. Proc. Natl. Acad. Sci. USA 87:4120.
9. 2-glycoprotein I. Lupus 3:207.
10. 2-glycoprotein I as an anticardiolipin cofactor determined using deleted mutants expressed by a baculovirus system. Blood 87:3262.
11. 2-glycoprotein I (apolipoprotein H). J. Clin. Invest. 90:1105.
12. 2-glycoprotein I or anticardiolipin antibodies alone. Clin. Exp. Immunol. 93:269.
13. 2-glycoprotein-I) induces experimental APS in naive mice. J. Autoimmun. 7:441.
14. 2-glycoprotein I. J.Invest. Med. 44:69A.
15. 2-glycoprotein I. Clin. Exp. Immunol. 101:78.
16. Mowat, A. M. 1987. The regulation of immune responses to dietary protein antigens. Immunol. Today 8:93.
17. Higgins, P., and H. L. Weiner. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:440.
18. Rizzo, L. V., N. E. Miller-Rivero, C. C. Chan, B. Wiggert, R. B. Nussenblatt, and R. R. Caspi. 1994. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest. 94:1668.
19. Weiner, H. L., A. Friedman, A. Miller, S. J. Khoury, A. Al-Sabbach, L. M. B. Santos, M. Sayegh, R. B. Nussenblatt, D. E. Trenthan, and D. A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
20. Weiner, H. L., G. A. Mackin, M. Matsui, E. J. Orav, S. J. Khoury, D. M. Dawson, and D. A. Hafler. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321.
21. Trentham, D. E., R. A. Dynesius-Trentham, E. J. Orav, D. Combitchi, C. Lorenzo, K. L. Sewell, D. A. Hafler, and H. L. Weiner. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727.
22. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J.Immunol. 147:2155.
23. Chen, Y., J. I. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells following oral tolerance. Nature 376:177.
24. + suppressor T cells. J.Immunol. 156:916.
25. + cells mediate active suppression. J.Immunol. 155:910.
26. Miller, A., O. Lider, A. B. Roberts, M. B. Sporn, and H. L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGF-β following antigen specific triggering. Proc. Natl. Acad. Sci. USA 89:421.
27. Son, C. O., M. Tomasi, M. T. Dertzbauelgh, G. Thaggard, R. Hunter, and C. Weaver. 1996. Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance. Ann. NY Acad. Sci. 778:156.
28. Khoury, S. J., O. Lider, A. Al-Sabbach, and H. L. Weiner. 1990. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell. Immunol. 131: 302.
29. Sun, J. B., J. Homgren, and C. Czerkinsky. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91:10795.
30. 2-glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fractions. Int. J. Biochem. 11:265.
31. Garside, P., M. Steel, E. A. Worthey, A. Satoskar, J. B. Alexander, H. Luethmann, F. Y. Liew, and A. M. Mowat. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J.Immunol. 154:5649.
32. Kim, J. H, and M. Ohsawa. 1995. Oral tolerance to ovalbumin in mice as a model for detecting modulators of the immunologic tolerance to a specific antigen. Biol. Pharm. Bull. 18:854.
33. Ma, C. G., G.-X. Zhang, B.-G. Xiao, Z.-Y. Wang, J. Link, T. Olsson, and H. Link. 1996. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down regulation of AChR-specific IFN-γ expressing Th1-like cells and upregulalion of TGFβ mRNA in mononuclear cells. Ann. NY Acad. Sci. 778:273.
34. Aramaki, Y., Y. Fuijii, H. Suda, I. Suzuki, T. Yadoma, and S. Tsuchiya. 1994. Induction of oral tolerance after feeding with ragweed pollen extract in mice. Immunol. Lett. 40:21.
35. Fredman, A., and H. L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91:6688.
36. Friedman, A. 1996. Induction of anergy in Th1 lymphocytes by oral tolerance: importance of antigen dosage and frequency of feeding. Ann. NY Acad. Sci. 778:103.
37. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into class I pathway of antigen processing and presentation. Cell 54:777.
38. Chen, Y., V. K. Kuchro, J. I. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
39. Keller, J. R., C. Mantel, G. K. Sing, L. R. Ellingsworth, S. K. Ruscetti, and F. W. Ruscetti. 1988. Transforming growth factor β selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med. 168:737.
40. Kehrl, J. H., L. M. Wakefield, A. B. Roerts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
41. Lee, G., L. R. Ellingsworth, S. Gillis, R. Wall, and P. W. Kincade. 1987. β Transforming growth factors are potential regulators of B lymphocytes. J. Exp. Med. 166:1290.
42. Espevik, T., I. Figari, M. Shalaby, G. Lackides, G. Lewis, M. Shepard, and M. Palladino. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor-β. J. Exp. Med. 166:571.
43. β1. J. Immunol. 151:668.
44. Panja, A., and L. Mayer. 1994. Diversity and function of antigen presenting cells in mucosal tissues.In Handbook of Mucosal Immunology. P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock, eds. Academic Press, San Diego, CA, p. 177.
45. Bland, P. W., and D. M. Kambarage. 1991. Antigen handing by the epithelium and lamina propria macrophages. Gastroenterol. Clin. North Am. 20:577.
46. Mayer, L., and R. Shilien. 1987. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 166:1471.
47. Zhang, X., T. Brunner, L. Carter, R. Dutton, P. Rogers, L. Bradley, T. Sato, J. Reed, D. Green, and S. Swain. 1997. Unequal death in T helper cell Th1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837.
48. Ngan, J., and S. L. Kind. 1978. Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerance by the oral administration of ovalbumin. J. Immunol. 120:861.
49. Stokes, C. R., T. J. Newby, J. H. Huntley, D. Patel, F. J. Bourne. 1979. The immune response of mice to bacterial antigens given by mouth. Immunology 38:497.
50. Alarcon-Segovia, D., and A. R. Cabral. 1996. The antiphospholipid/cofactor syndromes. J. Rheumatol. 23:8.